Related topics

Affimed N.V.: 3Q Earnings Snapshot

November 19, 2019

HEIDELBERG, Germany (AP) _ Affimed N.V. (AFMD) on Tuesday reported a loss of $12.1 million in its third quarter.

On a per-share basis, the Heidelberg, Germany-based company said it had a loss of 19 cents.

The drug developer posted revenue of $2.3 million in the period.

The company’s shares closed at $2.43. A year ago, they were trading at $4.26.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AFMD at https://www.zacks.com/ap/AFMD